CN114191314A - Mineral filling material and preparation method and application thereof - Google Patents
Mineral filling material and preparation method and application thereof Download PDFInfo
- Publication number
- CN114191314A CN114191314A CN202111454550.7A CN202111454550A CN114191314A CN 114191314 A CN114191314 A CN 114191314A CN 202111454550 A CN202111454550 A CN 202111454550A CN 114191314 A CN114191314 A CN 114191314A
- Authority
- CN
- China
- Prior art keywords
- filling material
- parts
- root canal
- mesh sieve
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 69
- 238000011049 filling Methods 0.000 title claims abstract description 62
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 21
- 239000011707 mineral Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 59
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000011787 zinc oxide Substances 0.000 claims abstract description 30
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 28
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 26
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229940116229 borneol Drugs 0.000 claims abstract description 25
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 241001676573 Minium Species 0.000 claims abstract description 20
- 210000004262 dental pulp cavity Anatomy 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 28
- 239000010634 clove oil Substances 0.000 claims description 21
- 238000000227 grinding Methods 0.000 claims description 12
- 239000012764 mineral filler Substances 0.000 claims description 12
- 238000007873 sieving Methods 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 14
- 238000011282 treatment Methods 0.000 abstract description 14
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 230000000704 physical effect Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 239000002631 root canal filling material Substances 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 239000000899 Gutta-Percha Substances 0.000 abstract description 3
- 240000000342 Palaquium gutta Species 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000003467 diminishing effect Effects 0.000 abstract description 3
- 229920000588 gutta-percha Polymers 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 238000007711 solidification Methods 0.000 abstract description 2
- 230000008023 solidification Effects 0.000 abstract description 2
- 235000014692 zinc oxide Nutrition 0.000 description 23
- 235000010755 mineral Nutrition 0.000 description 12
- 239000011133 lead Substances 0.000 description 5
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 4
- -1 borneolum Chemical compound 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010049077 Hernia pain Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- FAMPSKZZVDUYOS-OWEBEESNSA-N (1e,4z,8e)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound C\C1=C/CC(C)(C)\C=C/C\C(C)=C\CC1 FAMPSKZZVDUYOS-OWEBEESNSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 240000006890 Erythroxylum coca Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241000219926 Myrtaceae Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940095076 benzaldehyde Drugs 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000008957 cocaer Nutrition 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000007147 dental pulp necrosis Diseases 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 208000004480 periapical periodontitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 125000004591 piperonyl group Chemical group C(C1=CC=2OCOC2C=C1)* 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/56—Apical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Abstract
The invention belongs to the technical field of oral root canal filling materials, and discloses a mineral filling material, and a preparation method and application thereof. The filling material is prepared by matching zinc oxide, iodoform, minium, borneol and natural traditional Chinese medicine mineral raw materials, is used for filling the filling material for oral root canal therapy, improves the sterilization and convergence effects of the filling material, improves the physical properties of the filling material, improves the strength, reduces the contractility and is simple and easy to use. Not only improves the drug effect, but also improves the physical property, greatly reduces the shrinkage rate, forms a substance similar to gutta-percha, perfectly realizes the requirement of ideal oral root canal treatment paste, and greatly improves the oral root canal treatment effect. Has the effects of sterilizing, removing putrefaction, promoting granulation, promoting blood circulation, relieving pain, astringing, diminishing inflammation, and relieving pain. The shrinkage performance of the filling material after solidification is greatly improved, dead cavities are eliminated, and the success rate of root canal treatment is improved.
Description
Technical Field
The invention belongs to the technical field of oral root canal filling materials, and particularly relates to a mineral filling material and a preparation method and application thereof.
Background
Each tooth has a channel in its root, between which there are nerves, blood vessels, etc., called root canals. Root canal treatment generally includes three steps of root canal preparation, root canal disinfection and root canal filling: firstly, the inflammation and necrosis of dental nerves and a large amount of bacteria and putrefactive substances are thoroughly removed by instruments, and then the root canal filling material is put on, and the root canal is tightly filled, so that the infection spreading is prevented. The method is used for saving the affected teeth as far as possible from being pulled out, reducing the infection of the focus, rebuilding the health of the affected teeth and the like, and is an effective method for treating the irreversible pulpitis, the pulpal necrosis and various periapical periodontitis at present.
Therefore, the root canal filling material should have a continuous disinfection effect to promote the healing of periapical lesions, and it is important to select a filling material with an antibacterial component. In addition, the root canal filling material is required not to have obvious decomposition products, and the dissolubility is not more than 3 percent of the mass fraction; when tested according to the specified method, the diameter of each disc is 20-33 mm; the disk with the thickness of 2mm has the attenuation amount of X-ray not less than that of an aluminum plate with the thickness of 3 mm.
The existing filling material has the following defects: 1. the bactericidal power is single, the drug performance is weak, and the irritation is strong; 2. the filling material has insufficient physical properties, poor strength, large contractibility and insufficient filling performance.
Disclosure of Invention
In order to solve the above problems in the prior art, the present invention aims to provide a mineral filling material, a preparation method and an application thereof.
The technical scheme adopted by the invention is as follows: the mineral filling material is mainly prepared from the following raw materials in parts by mass:
70-85 parts of powder and 15-30 parts of clove oil;
the powder comprises 55-70 parts of zinc oxide, 5-10 parts of iodoform, 35-55 parts of minium and 3-5 parts of borneol.
The invention provides a mineral filling material which is suitable for being used in the process of oral root canal therapy. The filling material is prepared by matching zinc oxide, iodoform, red lead, borneol and natural traditional Chinese medicine mineral raw materials.
Compared with the prior art, the invention has the advantages that; 1, compared with the traditional filling material of zinc oxide, iodoform and clove oil, the mineral traditional Chinese medicine minium is added, the sterilization effect of the filling material is greatly improved, and the effects of removing putrefaction, promoting granulation, promoting blood circulation, relieving pain and astringing are utilized, so that the effects of diminishing inflammation and relieving pain are achieved. 2, the physical property of the filling material is greatly improved after the lead is added, a mixture of lead, zinc and iodine is formed, the strength and the toughness of the filling material are obviously improved, and the filling material can be made into a substance similar to gutta-percha. 3, the shrinkage performance of the solidified filling material is greatly improved, dead spaces are eliminated, and the success rate of root canal treatment is improved.
Preferably, the filling material is mainly prepared from the following raw materials in parts by mass:
75-82 parts of powder and 18-25 parts of clove oil;
the powder comprises 60-67 parts of zinc oxide, 6-9 parts of iodoform, 40-50 parts of minium and 3.5-4.5 parts of borneol.
Preferably, the filling material is mainly prepared from the following raw materials in parts by mass:
78 parts of powder and 22 parts of clove oil;
the powder comprises 65 parts of zinc oxide, 8 parts of iodoform, 45 parts of minium and 4 parts of borneol.
Zinc oxide, (ZnO), commonly known as zinc white, is an oxide of zinc. Is insoluble in water and soluble in acid and strong base. Zinc oxide is a commonly used chemical additive, and is widely applied to the manufacture of products such as plastics, silicate products, synthetic rubber, lubricating oil, paint, coating, ointment, adhesive, food, batteries, flame retardant and the like. The zinc oxide has large energy band gap and exciton constraint energy, high transparency and excellent normal temperature luminous performance, and is applied to products such as liquid crystal displays, thin film transistors, light emitting diodes and the like in the semiconductor field. In addition, the zinc oxide of fine particles also starts to function in the related art as a nano material.
Iodoform, used as a preservative. The iodoform has no antiseptic effect, and can slowly decompose free iodine to exhibit antiseptic effect when contacting tissue fluid, and the action lasts for about 1-3 days. Has low irritation to tissue and can promote granulation. Has antiseptic, deodorant and fly-proof effects. Can be used for fistula, deep wound, etc.
Plumbum preparatium, also known as Plumbum Preparatium, is known as Plumbum tetroxide. It is bright red powder at normal temperature. After mixing with oil, the product can be coated on ironware to prevent rusting. Sometimes used for relieving miliaria. The Plumbum Preparatium can directly kill bacteria and parasite, and has functions of inhibiting mucus secretion.
Borneol, other names: borneolum, Borneolum Syntheticum, borneolum, Borneolum Syntheticum, and Borneolum Syntheticum. The main components are as follows: the product is crystal obtained from resin and volatile oil of Borneolum, and is almost pure dextroborneol. The resin and volatile oil of Borneolum contain various terpenoids. In addition to borneol, it also contains parthenone such as humulene, beta-elemene, caryophyllene, etc., and triterpenoid such as oleanolic acid, hordenic acid, asiatic acid, camphol ketone, coca glycol, etc. Pungent and bitter in flavor and cool in nature. Enter heart and lung meridians. Unblocking orifices, dispelling stagnated fire, removing nebula, improving eyesight, relieving swelling and alleviating pain. It is indicated for wind stroke, vomiting, coma due to febrile disease, epilepsy due to convulsion, phlegm-phlegm, qi block, deafness, sore throat, aphtha, otitis media, carbuncle, swelling, hemorrhoid, nebula, and enterobiasis. 1. Antibacterial and anti-inflammatory effects; 2. effect on pregnancy.
Oleum Caryophylli is volatile oil obtained by distilling dried bud of flos Caryophylli of Myrtaceae. Warm stomach and kidney. Can be used for treating stomach cold, pain and distention, singultus, vomiting and diarrhea, arthralgia, hernia pain, halitosis, and toothache. Sweet and pungent in flavor and strong in heat. The functions are mainly as follows: warm stomach and kidney. It is used to treat stomach cold, pain and distention, singultus, vomiting and diarrhea, arthralgia, hernia pain, halitosis, and toothache. Chemical components: contains volatile oil 16-19%, eugenol and acetosyringol as main components, and eugenol, heptanone, methyl salicylate, alpha-caryophyllene, piperonyl, benzyl alcohol, benzaldehyde, etc. as trace components. The pharmacological action is as follows: flos Caryophylli has effects of stimulating gastric secretion, protecting gastric mucosa injury, relieving diarrhea, promoting bile flow, resisting anoxia, resisting blood coagulation, resisting mutation, inhibiting bacteria, and killing parasite.
A method of preparing a mineral filler material, the method comprising the steps of:
selecting zinc oxide, iodoform, minium and borneol according to corresponding proportion, grinding and sieving respectively, and mixing to obtain powder;
and selecting the powder according to a corresponding proportion, adding clove oil for blending to obtain a finished filling material product.
Preferably, the zinc oxide is sieved by a 500-880 mesh sieve;
the iodoform is screened by a 100-mesh and 600-mesh sieve.
Preferably, the red lead is sieved by an 800-;
the borneol is sieved by a 400-mesh 800-mesh sieve.
Preferably, the mixing time period is 10 to 60 minutes.
Preferably, the blending temperature of the clove oil is 25-27 ℃.
Use of a mineral filling material, the use of a finished product obtained by a mineral filling material according to any one of claims 1 to 3 or a process for the preparation of a mineral filling material according to any one of claims 4 to 8 as a filling material in the treatment of root canals in the oral cavity.
The invention has the beneficial effects that:
the invention provides a mineral filling material which is suitable for use in the course of oral root canal therapy. The filling material is prepared by matching zinc oxide, iodoform, red lead, borneol and natural traditional Chinese medicine mineral raw materials, is used for filling the filling material for oral root canal therapy, improves the disinfection, sterilization and convergence effects of the filling material, improves the physical properties of the filling material, improves the strength, reduces the contractility, and is simple and easy to use.
The filling material not only improves the drug effect, but also improves the physical property, the shrinkage rate is greatly reduced, a substance similar to gutta-percha is formed, the requirement of ideal oral root canal treatment paste is perfectly realized, and the oral root canal treatment effect is greatly improved.
The filling material has the effects of sterilization, removing putrefaction, promoting granulation, promoting blood circulation, relieving pain, astringing, diminishing inflammation and treating pain. The shrinkage performance of the filling material after solidification is greatly improved, dead cavities are eliminated, and the success rate of root canal treatment is improved.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. The reagents used are all conventional products which are commercially available.
Example 1:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 55 g of zinc oxide (screened by a 500-mesh sieve), 5 g of iodoform (screened by a 100-mesh sieve), 35 g of minium (screened by a 800-mesh sieve) and 3 g of borneol (screened by a 400-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 10 minutes to obtain powder;
68.6 g of powder (70 wt%) is selected according to the corresponding proportion, 29.4 g of clove oil (30 wt%) is added, and blending is carried out at 25 ℃ to obtain a finished filling material product.
Example 2:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 55 g of zinc oxide (screened by a 880-mesh sieve), 5 g of iodoform (screened by a 600-mesh sieve), 35 g of minium (screened by a 1000-mesh sieve) and 3 g of borneol (screened by a 800-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 60 minutes to obtain powder;
83.3 g of powder (85 wt%) is selected according to the corresponding proportion, 14.7 g of clove oil (15 wt%) is added, and blending is carried out at 27 ℃ to obtain a finished filling material product.
Example 3:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 70 g of zinc oxide (screened by a 500-mesh sieve), 10 g of iodoform (screened by a 100-mesh sieve), 55 g of minium (screened by a 800-mesh sieve) and 5 g of borneol (screened by a 400-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 10 minutes to obtain powder;
selecting 98 g of powder (70 wt%), adding 42 g of clove oil (30 wt%), and blending at 25 ℃ to obtain a finished filling material.
Example 4:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 70 g of zinc oxide (screened by a 880-mesh sieve), 10 g of iodoform (screened by a 600-mesh sieve), 55 g of minium (screened by a 1000-mesh sieve) and 5 g of borneol (screened by a 800-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 60 minutes to obtain powder;
119 g of powder (85 wt%) is selected according to the corresponding proportion, 21 g of clove oil (15 wt%) is added, and blending is carried out at 27 ℃ to obtain a finished filling material.
Example 5:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 60 g of zinc oxide (screened by a 500-mesh sieve), 6 g of iodoform (screened by a 100-mesh sieve), 40 g of minium (screened by a 800-mesh sieve) and 3.5 g of borneol (screened by a 400-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 10 minutes to obtain powder;
82.125 g of powder (75 wt%) is selected according to the corresponding proportion, 27.375 g of clove oil (25 wt%) is added, and blending is carried out at 25 ℃ to obtain a finished filling material product.
Example 6:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 60 g of zinc oxide (screened by a 880-mesh sieve), 6 g of iodoform (screened by a 600-mesh sieve), 40 g of minium (screened by a 1000-mesh sieve) and 3.5 g of borneol (screened by a 800-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 60 minutes to obtain powder;
89.79 g of powder (82 wt%) is selected according to the corresponding proportion, 19.71 g of clove oil (18 wt%) is added, and blending is carried out at 27 ℃ to obtain a finished filling material product.
Example 7:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 67 g of zinc oxide (screened by a 500-mesh sieve), 9 g of iodoform (screened by a 100-mesh sieve), 50 g of minium (screened by a 800-mesh sieve) and 4.5 g of borneol (screened by a 400-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 10 minutes to obtain powder;
97.875 g of powder (75 wt%) is selected according to the corresponding proportion, 32.625 g of clove oil (25 wt%) is added, and blending is carried out at 25 ℃ to obtain a finished filling material product.
Example 8:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 67 g of zinc oxide (screened by a 880-mesh sieve), 9 g of iodoform (screened by a 600-mesh sieve), 50 g of minium (screened by a 1000-mesh sieve) and 4.5 g of borneol (screened by a 800-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 60 minutes to obtain powder;
107.01 g of powder (82 wt%) is selected according to the corresponding proportion, 23.49 g of clove oil (18 wt%) is added, and blending is carried out at 27 ℃ to obtain a finished filling material product.
Example 9:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 65 g of zinc oxide (screened by a 500-mesh sieve), 8 g of iodoform (screened by a 100-mesh sieve), 45 g of minium (screened by a 800-mesh sieve) and 4 g of borneol (screened by a 400-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 10 minutes to obtain powder;
95.16 g of powder (78 wt%) is selected according to the corresponding proportion, 26.84 g of clove oil (22 wt%) is added, and blending is carried out at 25 ℃ to obtain a finished filling material product.
Example 10:
a method of preparing a mineral filler material, the method comprising the steps of:
selecting 65 g of zinc oxide (screened by a 880-mesh sieve), 8 g of iodoform (screened by a 600-mesh sieve), 45 g of minium (screened by a 1000-mesh sieve) and 4 g of borneol (screened by a 800-mesh sieve) according to corresponding proportions, grinding and sieving respectively, and mixing for 60 minutes to obtain powder;
95.16 g of powder (78 wt%) is selected according to the corresponding proportion, 26.84 g of clove oil (22 wt%) is added, and blending is carried out at 27 ℃ to obtain a finished filling material.
Clinical cases:
the patients: female, 31 years old.
Complaints of symptoms: toothache occurs for two weeks.
The current medical history: the hospital was filled with 11-and 12-root canal treatments.
Physical examination: the face is symmetrical and has no swelling, and the area of the apex of the root is examined to be 11 cold and hot (+) (not red and swollen).
Auxiliary inspection: and (4) carrying out fault treatment on a curved surface.
And (3) preliminary diagnosis: pulp necrosis.
And (3) treatment: 11 root canal treatments were performed.
The treatment results are as follows: has no discomfort and no irritation, and has good filling effect.
The present invention is not limited to the above alternative embodiments, and any other products in various forms can be obtained by the present invention, and the present invention is within the protection scope of the present invention. The above embodiments should not be construed as limiting the scope of the present invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the above embodiments, or equivalent substitutions may be made to some or all of the technical features thereof, without departing from the scope of the present invention, and at the same time, such modifications or substitutions may not make the essence of the corresponding technical solutions depart from the scope of the embodiments of the present invention.
Claims (9)
1. The mineral filling material is characterized by being prepared from the following raw materials in parts by mass:
70-85 parts of powder and 15-30 parts of clove oil;
the powder comprises 55-70 parts of zinc oxide, 5-10 parts of iodoform, 35-55 parts of minium and 3-5 parts of borneol.
2. The mineral filling material as claimed in claim 1, wherein the filling material is prepared from the following raw materials in parts by mass:
75-82 parts of powder and 18-25 parts of clove oil;
the powder comprises 60-67 parts of zinc oxide, 6-9 parts of iodoform, 40-50 parts of minium and 3.5-4.5 parts of borneol.
3. The mineral filling material as claimed in claim 2, wherein the filling material is prepared from the following raw materials in parts by mass:
78 parts of powder and 22 parts of clove oil;
the powder comprises 65 parts of zinc oxide, 8 parts of iodoform, 45 parts of minium and 4 parts of borneol.
4. A method for the preparation of the mineral filling material according to any one of claims 1 to 3, characterized in that it comprises the following steps:
selecting zinc oxide, iodoform, minium and borneol according to corresponding proportion, grinding and sieving respectively, and mixing to obtain powder;
and selecting the powder according to a corresponding proportion, adding clove oil for blending to obtain a finished filling material product.
5. The method as claimed in claim 4, wherein the zinc oxide is sieved through a 500-880 mesh sieve;
the iodoform is screened by a 100-mesh and 600-mesh sieve.
6. The method as claimed in claim 4, wherein the red lead is sieved through a 800-1000 mesh sieve;
the borneol is sieved by a 400-mesh 800-mesh sieve.
7. A method of preparing a mineral filler material as claimed in claim 4, wherein the mixing period is 10-60 minutes.
8. The method of claim 4, wherein the clove oil is blended at a temperature of 25-27 ℃.
9. Use of a mineral filling material according to any of claims 1 to 3 or a finished product obtained by a method of preparing a mineral filling material according to any of claims 4 to 8 as a filling material in oral root canal therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111454550.7A CN114191314A (en) | 2021-12-01 | 2021-12-01 | Mineral filling material and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111454550.7A CN114191314A (en) | 2021-12-01 | 2021-12-01 | Mineral filling material and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114191314A true CN114191314A (en) | 2022-03-18 |
Family
ID=80649964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111454550.7A Pending CN114191314A (en) | 2021-12-01 | 2021-12-01 | Mineral filling material and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114191314A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1899240A (en) * | 2006-07-07 | 2007-01-24 | 安泰科技股份有限公司 | Nano zinc oxide clove oil root canal filling material and its preparing method |
| WO2007139442A1 (en) * | 2006-06-01 | 2007-12-06 | Obschestvo S Ogranichennoi Otvetstvennostuy 'vmpavto' | Finishing lapping concentrate containing modifying mineral fillers |
| CN107753302A (en) * | 2017-12-07 | 2018-03-06 | 北京大学口腔医学院 | A kind of paste and its preparation method and application |
-
2021
- 2021-12-01 CN CN202111454550.7A patent/CN114191314A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007139442A1 (en) * | 2006-06-01 | 2007-12-06 | Obschestvo S Ogranichennoi Otvetstvennostuy 'vmpavto' | Finishing lapping concentrate containing modifying mineral fillers |
| CN1899240A (en) * | 2006-07-07 | 2007-01-24 | 安泰科技股份有限公司 | Nano zinc oxide clove oil root canal filling material and its preparing method |
| CN107753302A (en) * | 2017-12-07 | 2018-03-06 | 北京大学口腔医学院 | A kind of paste and its preparation method and application |
Non-Patent Citations (1)
| Title |
|---|
| 邹长青等: "《中药袖珍辞典》", 湖南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Iwamoto et al. | Clinical and histological evaluation of white ProRoot MTA in direct pulp capping | |
| CN104188855B (en) | Traditional Chinese medicine toothpaste with effects of preventing and relieving tooth sensitivity | |
| CN109481527B (en) | Traditional Chinese medicine composition for preventing or treating oral diseases and application thereof | |
| RU2624131C1 (en) | Method of treatment of chronic apical periodontitis | |
| CN106236612B (en) | Toothpaste and preparation method thereof | |
| CN110051541B (en) | Calcium hydroxide root canal disinfection paste and preparation method thereof | |
| CN114191314A (en) | Mineral filling material and preparation method and application thereof | |
| RU2372949C1 (en) | Method for treating inflammatory parodentium diseases | |
| CN114028327B (en) | Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof | |
| Madan et al. | A comparative evaluation between propolis and mineral trioxide aggregate as pulpotomy medicaments in primary molars | |
| Arslan et al. | Effect of calcium hydroxide mixed with lidocaine hydrochloride on postoperative pain in teeth with irreversible pulpitis and symptomatic apical periodontitis: a preliminary randomized controlled prospective clinical trial | |
| WO2020087766A1 (en) | Use of benzofuran derivative | |
| Scotti et al. | Anti-inflammatory and wound healing effects of an essential oils-based bioadhesive gel after oral mucosa biopsies: Preliminary results | |
| CN102198069B (en) | Lamiophlomis rotata toothpaste and preparation method thereof | |
| CN113633738A (en) | Traditional Chinese medicine spray | |
| CN112245498A (en) | Antipruritic ointment combining Chinese medicine and western medicine and preparation method thereof | |
| RU2330645C2 (en) | Method of periodontitis treatment | |
| CN103933274A (en) | Traditional Chinese medicine preparation for treating periodontitis | |
| Boj et al. | Treatment of Pyogenic Granuloma with a Laser-powered Hydrokinetic System: Case Report. | |
| TWI730286B (en) | Preparation method and usage of oral composition | |
| RU2545761C1 (en) | Root canal filling paste for treating periodontitis | |
| Hammouti et al. | Non-surgical management of large periapical cyst like lesion: case report and litterature review | |
| RU2678199C1 (en) | Method of treatment of alveolitis tooth hole | |
| Jain et al. | Single Visit Apexification Technique for Inducing Root-End Barrier Formation in Apical Closures: Report of Two Cases | |
| RU2569762C1 (en) | Material for filling root canals of teeth in treating destructive forms of chronic periodontitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220318 |